One-pot synthesis of β-cyclodextrin amended mesoporous cerium(IV) incorporated ferric oxide surface towards the evaluation of fluoride removal efficiency from contaminated water for point of use.

Surface modified Cerium(IV)-incorporated hydrous Fe(III) oxide (CIHFO) with β-cyclodextrin (β-CD) nanocomposite (βC-CIHFO) has been developed by in-situ wet chemical deposition method and characterized by means of some analytical tools such as FTIR, XRD,OM, SEM-EDX, TEM-EDX, AFM, TG-DTA and BET surface area analyses, resembled the irregular and undulated surface morphology consisting of microcrystals (∼2-3 nm) and mesoporous (∼6.022 nm) structure confirm surface amended CIHFO with β-CD. Enhanced fluoride adsorption capacity of βC-CIHFO (107.

Depletion of Cr(VI) from aqueous solution by heat dried biomass of a newly isolated fungus Arthrinium malaysianum: A mechanistic approach.

For the first time, the heat dried biomass of a newly isolated fungus Arthrinium malaysianum was studied for the toxic Cr(VI) adsorption, involving more than one mechanism like physisorption, chemisorption, oxidation-reduction and chelation. The process was best explained by the pseudo-second order kinetic model and Redlich-Peterson isotherm with maximum predicted biosorption capacity (Q ) of 100.69 mg g.

A randomized comparative study on modified Joel-Cohen incision versus Pfannenstiel incision for cesarean section.

Objective: Pfanennstiel incision is the most commonly used incision for cesarean section, but may not be the best. This study compared the modified Joel-Cohen incision with the Pfannenstiel incision to evaluate whether techniques to open the abdomen might influence operative time, and maternal and neonatal outcomes.

Material And Methods: In a randomized comparative trial, 302 women with gestational age >34 weeks, requiring cesarean section, were randomly assigned to either modified Joel-Cohen incision or Pfannenstiel incision for entry into the peritoneal cavity.

Efficacy of intra-umbilical oxytocin in the management of retained placenta: a randomized controlled trial.

Aim: Retained placenta is an important cause of maternal mortality. The present study was aimed to determine the efficacy of umbilical injection of oxytocin as a treatment modality in this condition.

Material And Methods: This was a single-center randomized controlled trial incorporating 58 women with retained placenta of more than 30 min, equally distributed into two study arms of intra-umbilical injection of oxytocin (50 IU oxytocin diluted with normal saline [NS] to a total volume 30 mL) and intra-umbilical injection of NS (30 mL).